1. A. A licensed perfusionist may practice only under the supervision of a licensed physician.
2. B. The scope of practice of a licensed perfusionist is performance of the functions necessary for the support, treatment, measurement, or supplementation of the cardiovascular, circulatory, or respiratory systems, or other organs to ensure the safe management of physiologic functions by monitoring and analyzing the parameters of the systems.

3. C. The scope of practice of a licensed perfusionist includes the following special procedures, performed on the order of and under the supervision of a licensed physician:

   1. (1) Cardiopulmonary bypass for adult, pediatric, and neonatal patients;
   2. (2) Extracorporeal circulatory support for renal, neurological, hepatic, and vascular surgery;
   3. (3) Extracorporeal resuscitation;
   4. (4) Extracorporeal circulation for long-term support of failing respiratory or cardiac function;
   5. (5) Extracorporeal membrane oxygenation;
   6. (6) Extracorporeal carbon dioxide removal;
   7. (7) Myocardial protection;
   8. (8) Perfusion-assisted direct coronary artery bypass;
   9. (9) Hemofiltration and hemodialysis;
   10. (10) Anticoagulation and hemostasis monitoring, analysis, and intervention;
   11. (11) Thermal regulation;
   12. (12) Blood gas and blood chemistry monitoring, analysis, and intervention;
   13. (13) Physiological monitoring, analysis, and intervention;
   14. (14) Administration of blood components and pharmaceuticals;
   15. (15) Administration of anesthetic agents through a heart lung machine at the direction of an anesthesiologist;
   16. (16) Ventricular assist device and mechanical circulatory support management;
   17. (17) Intra-aortic balloon counterpulsation;
   18. (18) Temporary pacemaker management;
   19. (19) Periodic flow augmentation therapy;
   20. (20) Autotransfusion;
   21. (21) Platelet gel production, autologous hemocyte tissue matrix production;
   22. (22) Nondifferentiated progenitor cell harvest bone marrow aspirate concentration;
   23. (23) Acute normovolemic hemodilution;
   24. (24) Isolated limb or organ delivery of chemotherapeutics, progenitor cells, gene therapy vectors, and other items;
   25. (25) Organ procurement and preservation;
   26. (26) Thermogenic lavage;
   27. (27) Electrophysiological analysis;
   28. (28) Therapeutic hyperthermia;
   29. (29) Intravascular membrane oxygenation; and
   30. (30) Renal perfusion.

Authority: Health Occupations Article, §§1-221, 1-606, 14-205, 14-5E-01 — 14-5E-20, and 14-5E-23, Annotated Code of Maryland

Effective date: September 15, 2014 (41:18 Md. R. 1010)

Regulation .02B amended effective January 19, 2026 (53:1 Md. R, 21)

Regulation .03 amended effective January 19, 2026 (53:1 Md. R, 21)

Regulation .03A amended effective August 15, 2016 (43:16 Md. R. 900)

Regulation .06 amended effective January 19, 2026 (53:1 Md. R, 21)

Regulation .08B amended effective August 15, 2016 (43:16 Md. R. 900)

Regulation .09A amended effective August 15, 2016 (43:16 Md. R. 900)

Regulation .09D, E adopted effective August 15, 2016 (43:16 Md. R. 900)

Regulation .10 amended effective August 15, 2016 (43:16 Md. R. 900); January 19, 2026 (53:1 Md. R, 21)

Regulation .11B amended effective January 19, 2026 (53:1 Md. R, 21)

Regulation .14 amended effective January 19, 2026 (53:1 Md. R, 21)

Regulation .15 amended effective August 15, 2016 (43:16 Md. R. 900)

Regulation .15B amended effective January 19, 2026 (53:1 Md. R, 21)

Regulation .16A amended effective January 19, 2026 (53:1 Md. R, 21)

Regulation .17B, C amended effective August 15, 2016 (43:16 Md. R. 900)

Regulation .18 amended effective August 15, 2016 (43:16 Md. R. 900)

Regulation .18A, C amended effective January 19, 2026 (53:1 Md. R, 21)